Fingerprint
Dive into the research topics of 'A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion
Gladys I. Rodriguez, John G. Kuhn, Geoffrey Weiss, Pearl De La Cruz, Pamela New, Suzanne M. Fields, John R. Eckardt, Liz Campbell, Gary M. Clark, Susan G. Hilsenbeck, Daniel D. Von Hoff
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations